Published 2 years ago

FDA chief admits slow response to formula shortage

Summary by Ground News

FDA Commissioner Robert Califf testifies before a House subcommittee. Califf lays out a series of setbacks that slowed his agency's response. The shortage largely stems from Abbott's Michigan plant, which the FDA shut down in February. Abbott and the FDA have reached an agreement to reopen the plant next week.

0 Articles

All

Left

Center

Right

Reuters

Lawmakers grill U.S. FDA on response to Abbott baby formula safety

Lawmakers grilled U.S. Food and Drug Administration officials on Wednesday over what they saw as a lack of urgency in the agency's response to complaints about possible baby formula contamination at a now shuttered Abbott Laboratories plant that led to severe nationwide shortages.

2 years ago·United Kingdom

Read Full Article

USA Today

Baby formula shortage: FDA chief admits federal regulators were 'too slow' to act

The baby formula shortage will drag on at least another month, according to testimony Wednesday.

2 years ago·United States

Read Full Article

Washington Times

FDA admits hobbled response to baby formula crisis

Top officials at the Food and Drug Administration admitted they took too long to respond to a baby formula shortage and were hobbled by bad decisions and COVID-related problems, including a whistleblower report about a formula factory that was lost in the mail.

2 years ago·United States

Read Full Article

CBS News

FDA chief struggles to explain its slow response on baby formula

Commissioner Robert Califf admitted the agency's reaction was "too slow," while a formula maker exec apologized to parents.

2 years ago

Read Full Article

The Hill

FDA chief admits slow response to formula shortage

The Food and Drug Administration’s (FDA) response to multiple reports of contamination at a baby formula manufacturing plant was delayed due to a COVID-19 outbreak and numerous logistical fai…

2 years ago·Washington, United States

Read Full Article

IBTimes

U.S. FDA Defends Baby Formula Shortage Response In Congress

The U.S. Food and Drug Administration on Wednesday in testimony to lawmakers defended the steps it took to address complaints about possible baby formula contamination at an Abbott Laboratories plant that has been closed since February. FDA leaders are appearing before a congressional panel to answer questions about one of the biggest infant formula shortages in recent U.S. history after Abbott in February recalled some products and closed its m…

2 years ago·United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.